Blog
About

  • Record: found
  • Abstract: found
  • Article: not found

Helix 3 is necessary and sufficient for prion protein's anti-Bax function.

Journal of Neurochemistry

metabolism, Alanine, chemistry, Amino Acid Sequence, physiology, Amino Acid Substitution, Animals, Apoptosis, Cell Line, Tumor, Cells, Cultured, Cytoprotection, genetics, Humans, Mice, Neoplasms, Nerve Degeneration, PrPC Proteins, Prion Diseases, physiopathology, Proline, Protein Structure, Secondary, bcl-2-Associated X Protein

Read this article at

ScienceOpenPublisherPMC
Bookmark
      There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.

      Abstract

      To identify the structural elements of the prion protein (PrP) necessary for its protective function against Bcl-2 associated protein X (Bax), we performed structure-function analyses of the anti-Bax function of cytosolic PrP (CyPrP) in MCF-7 cells. Deletions of 1, 2, or 3 N-terminal Bcl-2 homology domain 2-like octapeptide repeats (BORs), but not deletion of all four BORs, abolish CyPrPs anti-Bax function. Deletion of alpha-helix 3 (PrP23-199) or further C-terminal deletions of alpha-helix 1 and 2, and beta-strand 1 and 2 (PrP23-172, PrP23-160, PrP23-143, and PrP23-127) eliminates CyPrPs protection against Bax-mediated cell death. The substitution of helix 3 amino acid residues K204, V210, and E219 by proline inhibits the anti-Bax function of CyPrP. The substitution of K204, but not V210 and E219, by alanine residues also prevents CyPrPs anti-Bax function. Expression of PrPs helix 3 displays anti-Bax activity in MCF-7 cells and in human neurons. Together, these results indicate that although the BOR domain has an influence on PrPs anti-Bax function, the helix 3 is necessary and sufficient for the anti-Bax function of CyPrP. Identification of helix 3 as the structural element for the anti-Bax function thus provides a molecular target to modulate PrPs anti-Bax function in cancer and neurodegeneration.

      Related collections

      Author and article information

      Journal
      19196429
      2710996
      10.1111/j.1471-4159.2008.05851.x

      Comments

      Comment on this article